Skip to main
UHS

UHS Stock Forecast & Price Target

UHS Analyst Ratings

Based on 12 analyst ratings
Hold
Strong Buy 17%
Buy 25%
Hold 50%
Sell 8%
Strong Sell 0%

Bulls say

Universal Health Services Inc. has demonstrated strong financial performance, with the Acute Care Hospital Services segment achieving a substantial adjusted EBITDA margin expansion of 190 basis points to 15.8%. The company reported an impressive 12.8% year-over-year growth in same-store revenue for the acute segment, driven by an increase in patient day growth and revenue per adjusted admission. Furthermore, anticipated benefits from pending CMS programs, along with expected margin improvements due to easing labor and cost pressures, contribute to a favorable outlook for the company's future earnings growth.

Bears say

The negative outlook on Universal Health Services Inc. stems from projected earnings that are expected to be approximately 5% lower than earlier estimates, influenced by volume and margin headwinds. Additionally, the company's long-term behavioral volume growth forecast has been adjusted downward, which could negatively impact anticipated EBITDA contributions, especially with projections indicating a significant decline starting in 2028. Furthermore, risks such as potential regulatory changes, high market concentration, and tight clinical labor supply are likely to exacerbate pressures on productivity and margins across the company's segments.

UHS has been analyzed by 12 analysts, with a consensus rating of Hold. 17% of analysts recommend a Strong Buy, 25% recommend Buy, 50% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Universal Health Services and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Universal Health Services (UHS) Forecast

Analysts have given UHS a Hold based on their latest research and market trends.

According to 12 analysts, UHS has a Hold consensus rating as of Dec 29, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $233.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $233.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Universal Health Services (UHS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.